A carregar...
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
Interstitial lung disease (ILD) represents a severe pulmonary complication of connective tissue diseases, rheumatoid arthritis (RA), and antineutrophil cytoplasmic antibody-associated vasculitis. Treatment of ILD, mainly based on immunosuppression, remains challenging. Rituximab (RTX), a monoclonal...
Na minha lista:
| Publicado no: | Drugs Context |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioExcel Publishing Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7813433/ https://ncbi.nlm.nih.gov/pubmed/33505478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-8-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|